Leukocyte Adhesion Deficiency Type
📧 Sign up to get email alerts when something new happens for Leukocyte Adhesion Deficiency Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Apheresis of Patients With Immunodeficiency
An NCI-sponsored clinical trial evaluating apheresis in patients with immunodeficiencies including leukocyte adhesion deficiency type 1, DOC…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Evaluation of Patients With Immune Function Abnormalities
The NIAID-sponsored study evaluating patients with immune function abnormalities (chronic granulomatous disease, X-linked severe combined im…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
Clinical trial update reporting long-term follow-up data for a gene therapy treating Leukocyte Adhesion Deficiency type I (LAD-I); the study…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology [Phase 1, Phase 2]
Clinical trial update on ustekinumab for inflammatory pathology in Leukocyte adhesion deficiency type 1 (LAD1); the Phase 1/2 study has comp…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I [Phase 1, Phase 2]
Clinical trial evaluating safety and efficacy of RP-L201 in subjects with Leukocyte Adhesion Deficiency-I (Phase 1/2) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I [Phase 2]
A Phase 2 clinical trial evaluating interferon gamma-1b for leukocyte adhesion deficiency type I has completed. The study reports the trial …
-
FDA approval ·FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
FDA approves the first gene therapy (Kresladi) for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I).